Condition: Substance Use Disorders · Mental Disorder · Sponsor: Sykehuset Innlandet HF
ROPVR, a multi-centre, pragmatic randomized controlled trial (RCT) aims to evaluate a VR-technology which has been developed within an exploratory study and a development study, which facilitates social functioning among persons with a substance use and mental health disorder. Investigators will test a VR-program versus treatment as usual among patients enrolled into a long-term addiction-treatment facility. The RCT aims to evaluate the effectiveness of VR training compared to treatment as usual in improving resilience, quality of life, practical and social functioning and social participation (from baseline to 6 months), and to evaluate the cost-effectiveness of VR training versus treatment as usual.
This description comes directly from the study's public registry record.
Marja Leonhardt, PhD · +4747150465 · marja.leonhardt@sykehuset-innlandet.no
Lars Lien, MD, PhD · +4797040683 · lars.lien@sykehuset-innlandet.no
Always discuss trial participation with your own doctor first.
| Innlandet Hospital Trust | Brumunddal, Norway | Recruiting |
| Sykehuset Innlandet HF | Hamar, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06677515